Page last updated: 2024-08-18

fluorodeoxyuridylate and Cancer of Testis

fluorodeoxyuridylate has been researched along with Cancer of Testis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ballmer-Hofer, K; Klemenz, R; Marty, C; Neri, D; Odermatt, B; Schott, H; Schwendener, RA1

Other Studies

1 other study(ies) available for fluorodeoxyuridylate and Cancer of Testis

ArticleYear
Cytotoxic targeting of F9 teratocarcinoma tumours with anti-ED-B fibronectin scFv antibody modified liposomes.
    British journal of cancer, 2002, Jul-01, Volume: 87, Issue:1

    Topics: Animals; Antibodies, Neoplasm; Antineoplastic Agents; Cytarabine; Female; Fibronectins; Fluorodeoxyuridylate; Immunoglobulin Fragments; Injections, Intravenous; Liposomes; Male; Mice; Mice, Nude; Teratocarcinoma; Testicular Neoplasms; Tissue Distribution; Tumor Cells, Cultured

2002